Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Eli-Lilly
Company Monitoring Page for Eli-Lilly
latest headlines for company on cafepharma
US judge overturns Eli Lilly's $176.5 million loss in Teva patent case
Reuters
Tue, 09/26/23 - 09:49 pm
Tags:
Eli Lilly
,
Teva Pharmaceutical
,
migraines
,
Ajovy
,
Emgality
,
patents
,
legal
Eli Lilly receives UK approval for ulcerative colitis treatment
Biopharma Reporter
Mon, 09/25/23 - 10:13 am
Tags:
Eli Lilly
,
NICE
,
UK
,
ulcerative colitis
,
mirikizumab
FDA greenlights Jardiance for treating chronic kidney disease
Medical Marketing and Media
Fri, 09/22/23 - 11:50 am
Tags:
Eli Lilly
,
Boehringer Ingelheim
,
Medicare
,
Jardiance
,
FDA
,
chronic kidney disease
Cell therapy developer closes funding round to support diabetes program
BioPharma Dive
Thu, 09/21/23 - 11:48 am
Tags:
cell therapy
,
Seraxis
,
funding
,
Eli Lilly
Eli Lilly sues clinics allegedly selling knockoff versions of Mounjaro diabetes drug
CNBC
Tue, 09/19/23 - 10:26 pm
Tags:
Eli Lilly
,
legal
,
Mounjaro
,
diabetes
Novo, Lilly set to dominate $71B GLP-1 drug market by 2032: J.P. Morgan
Fierce Pharma
Mon, 09/11/23 - 12:05 pm
Tags:
Novo Nordisk
,
Eli Lilly
,
GLP-1 agonist
,
obesity
The Alzheimer’s Treatment Landscape: Leqembi vs. Donanemab
BioSpace
Mon, 09/11/23 - 11:56 am
Tags:
Alzheimer's disease
,
Eli Lilly
,
Biogen
,
Eisai
,
Leqembi
,
donanemab
Patent cliffs, divestitures and maturing biotechs all point to more pharma M&A: analysts
Fierce Pharma
Fri, 09/8/23 - 10:29 am
Tags:
M&A
,
patent cliffs
,
Merck
,
JNJ
,
Pfizer
,
GSK
,
Novartis
,
Eli Lilly
,
Novo Nordisk
NICE changes its mind on Lilly's Mounjaro for diabetes
Pharmaphorum
Fri, 09/8/23 - 10:09 am
Tags:
Eli Lilly
,
Mounjaro
,
diabetes
,
NHS
,
UK
The 10 highest value R&D projects in biopharma
Fierce Biotech
Wed, 09/6/23 - 10:17 am
Tags:
R&D
,
biotech
,
Merck
,
sotatercept
,
Daiichi Sankyo
,
AstraZeneca
,
Dato-DXd
,
Novo Nordisk
,
CagriSema
,
Eli Lilly
,
donanemab
,
Karuna Therapeutics
,
Zai Lab
,
KarXT
,
Moderna Therapeutics
,
mRNA-1647
,
Novartis
,
iptacopan
,
Madrigal Pharmaceuticals
,
resmetirom
,
Cytokinetics
,
aficamten
,
Roche
,
Chugai
,
tiragolumab
Competing in These 3 Markets Could Send Eli Lilly Stock Soaring
Motley Fool
Tue, 09/5/23 - 11:23 am
Tags:
Eli Lilly
,
Alzheimer's disease
,
obesity
,
painkillers
Eli Lilly infiltrates anti-obesity market as Phase III trial for retatrutide begins
Clinical Trials Arena
Thu, 08/31/23 - 06:02 pm
Tags:
Eli Lilly
,
retatrutide
,
clinical trials
,
NASH
,
obesity
,
diabetes
,
type 2 diabetes
US senators push drugmakers for details on low-cost insulin programs
Yahoo/Reuters
Thu, 08/31/23 - 10:11 am
Tags:
Senate
,
insulin
,
drug pricing
,
Novo Nordisk
,
Eli Lilly
,
Sanofi
,
diabetes
With $25K donation to Pence PAC, Lilly CEO Ricks defies some of company's stated positions
Fierce Pharma
Wed, 08/30/23 - 11:22 pm
Tags:
Eli Lilly
,
Pharma CEOs
,
Dave Ricks
,
Mike Pence
,
2024 Presidential election
Biden administration lists 10 drugs for Medicare price negotiation
Medical Marketing and Media
Tue, 08/29/23 - 11:43 am
Tags:
Medicare
,
HHS
,
Pfizer
,
Bristol Myers Squibb
,
Eli Lilly
,
Boehringer Ingelheim
,
AstraZeneca
,
AbbVie
,
Novo Nordisk
,
JNJ
,
drug pricing
Lilly’s Cholesterol Pill Shows Early Promise in Phase I Study
BioSpace
Tue, 08/29/23 - 11:15 am
Tags:
Eli Lilly
,
muvalaplin
,
clinical trials
,
cholesterol
More US States Take on Eli Lilly in Court Over Proposed $13.5 Million Insulin Pricing Settlement
Xtalks
Sun, 08/27/23 - 04:38 pm
Tags:
Eli Lilly
,
legal
,
insulin
,
Humalog
,
drug pricing
,
Arizona
,
Mississippi
,
Minnesota
Lilly’s Retevmo Shows Superior Survival in Phase III Thyroid Cancer Trial
BioSpace
Wed, 08/23/23 - 10:12 am
Tags:
Eli Lilly
,
Retevmo
,
thyroid cancer
,
medullary thyroid cancer
,
clinical trials
,
Exelixis
,
Capometyx
,
Sanofi
,
Caprelsa
Zacks Industry Outlook Highlights Eli Lilly, J&J, Novo Nordisk, Novartis and AstraZeneca
Yahoo/Zacks.com
Tue, 08/22/23 - 09:58 am
Tags:
earnings
,
Eli Lilly
,
JNJ
,
Novo Nordisk
,
Novartis
,
AstraZeneca
Lilly's $13.5M insulin pricing settlement gets pushback from 9 states
Fierce Pharma
Thu, 08/17/23 - 10:16 am
Tags:
Eli Lilly
,
drug pricing
,
insulin
,
Humalog
,
legal
,
diabetes
Pages
« first
‹ previous
…
11
12
13
14
15
16
17
18
19
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.